Brief: Cellipont Bioservices And Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership To Advance Erna-101 Toward Clinical Trials In Ovarian Cancer
Ernexa Therapeutics Inc ERNA.O: CELLIPONT BIOSERVICES AND ERNEXA THERAPEUTICS ENTER CELL THERAPY MANUFACTURING PARTNERSHIP TO ADVANCE ERNA-101 TOWARD CLINICAL TRIALS IN OVARIAN CANCER Source text: ID:nPn4SGr2Sa Further company coverage: ERNA.O